SCHEMBL24205751

SCHEMBL24205751

O=C(Cc1c[nH]c2ccc(O)cc12)OCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.64
LMNA P02545 4/20 0.64
NPSR1 Q6W5P4 3/20 0.64
TSHR P16473 2/20 0.64
NFKB1 P19838 2/20 0.64
PMP22 Q01453 2/20 0.64
GLA P06280 1/20 0.64
CYP2C9 P11712 1/20 0.64
HPGD P15428 1/20 0.64
NR4A1 P22736 1/20 0.58
KMT2A Q03164 4/20 0.56
MAPT P10636 3/20 0.56
MEN1 O00255 3/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
PKM P14618 1/20 0.53
TRPV1 Q8NER1 4/20 0.53
CYP3A4 P08684 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C19 P33261 1/20 0.52
CASP1 P29466 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17369627 0.88 PKM (0.57) ALDH1A1LMNANPSR1TSHRNFKB1
SCHEMBL6100777 0.87 MEN1 (0.74) ALDH1A1LMNAHPGDKMT2AMAPT
SCHEMBL19749133 0.85 KDM4E (0.67) KMT2AMAPTMEN1KDM4EHTR2A
SCHEMBL5177499 0.83 PKM (0.68) ALDH1A1LMNANPSR1TSHRNFKB1
SCHEMBL8802846 0.80 TRPM8 (0.68) ALDH1A1NPSR1HPGDMAPTTRPV1
SCHEMBL853729 0.80 NPSR1 (0.68) ALDH1A1LMNANPSR1TSHRNFKB1
SCHEMBL2463168 0.80 NPSR1 (0.60) ALDH1A1LMNANPSR1TSHRNFKB1
SCHEMBL7023934 0.80 LMNA (0.64) ALDH1A1LMNANPSR1TSHRNFKB1
SCHEMBL7835246 0.79 TDP1 (0.52) ALDH1A1LMNANPSR1TSHRNFKB1
SCHEMBL138121 0.79 NPSR1 (1.00) ALDH1A1LMNANPSR1TSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017432-A1 CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING Reiley Pharmaceuticals, Inc. 2022-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220017432-A1 CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING PTGES3, PTGES, HPGDS ALDH1A1 626/4885LMNA 3803/4885NPSR1 219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.